Primerica's Q1 2022 results showed an 8% increase in total revenues to $691.2 million, but a 17% decrease in net income to $81.4 million. EPS decreased by 16% to $2.06. The company faced headwinds in the Senior Health segment, while the Term Life and Investment and Savings Products segments showed revenue growth.
Life-licensed sales force decreased 1% year-over-year to 130,206.
Term Life net premiums increased 9%, and adjusted direct premiums increased 10%.
Investment and Savings Products sales increased 7% to $3.1 billion.
Net earnings per diluted share (EPS) decreased 16% to $2.06.
Primerica expects to repurchase a total of $306 million of common stock during 2022.
Visualization of income flow from segment revenue to net income